search
Back to results

Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG

Primary Purpose

Diabetes

Status
Terminated
Phase
Not Applicable
Locations
Japan
Study Type
Interventional
Intervention
;Accu-Chek Compact Plus LCM bulk Japan
Sponsored by
Hoffmann-La Roche
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Diabetes

Eligibility Criteria

20 Years - undefined (Adult, Older Adult)All Sexes

Inclusion Criteria:

1. Age:= and >20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and >7.5% in the recect 2 months.

Exclusion Criteria:

1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor

Sites / Locations

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Single arm

Arm Description

Outcomes

Primary Outcome Measures

Improvement in HbA1c in 6 months

Secondary Outcome Measures

1. Comparison with historical control in HbA1c change.
2. Change in blood gulucose.
3. Change in BMI.
4. Occurance of sever hypoglycemia.
5. Doctor's opinion for Accu-Chek 360° View.

Full Information

First Posted
March 11, 2013
Last Updated
September 2, 2016
Sponsor
Hoffmann-La Roche
search

1. Study Identification

Unique Protocol Identification Number
NCT01820169
Brief Title
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Official Title
Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG
Study Type
Interventional

2. Study Status

Record Verification Date
September 2016
Overall Recruitment Status
Terminated
Why Stopped
Only 2 patients screened but none of them were enrolled.
Study Start Date
April 2013 (undefined)
Primary Completion Date
December 2013 (Actual)
Study Completion Date
December 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hoffmann-La Roche

4. Oversight

5. Study Description

Brief Summary
This clinical study is to determine if the use of structured testing, which is a blood glucose monitoring, via the Accu-Chek 360° View blood glucose analysis tool has a positive effect on the subjects overall glycemic control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Single arm
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
;Accu-Chek Compact Plus LCM bulk Japan
Intervention Description
HbA1c would be changed by more careful control in blood glucose with SMBG.
Primary Outcome Measure Information:
Title
Improvement in HbA1c in 6 months
Time Frame
6 months
Secondary Outcome Measure Information:
Title
1. Comparison with historical control in HbA1c change.
Time Frame
Baseline to 6 months
Title
2. Change in blood gulucose.
Time Frame
Baseline to 6 months
Title
3. Change in BMI.
Time Frame
Baseline to 6 months
Title
4. Occurance of sever hypoglycemia.
Time Frame
Baseline to 6 months
Title
5. Doctor's opinion for Accu-Chek 360° View.
Time Frame
Baseline to 6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Eligibility Criteria
Inclusion Criteria: 1. Age:= and >20 years. 2. Intend to paticipate in this study after education of structured testing. 3.HbA1c:= and >7.5% in the recect 2 months. Exclusion Criteria: 1.Pregancy. 2. Heavy complication 3. judged unsuitable by doctor
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Naoki Sakane
Organizational Affiliation
National organization Hospital Kyoto Medical Center
Official's Role
Principal Investigator
Facility Information:
City
Kyoto
ZIP/Postal Code
612-8555
Country
Japan

12. IPD Sharing Statement

Learn more about this trial

Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBG

We'll reach out to this number within 24 hrs